CervoMed Inc. Investment Income, Interest
CervoMed Inc. (CRVO) reported Investment Income, Interest of $104.90 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-07
- CervoMed Inc. investment income, interest for the quarter ending 2026-06-30 was $104.90K, a 71.51% decline year-over-year.
- CervoMed Inc. investment income, interest for the quarter ending 2026-03-31 was $147.39K, a 63.96% decline year-over-year.
- CervoMed Inc. investment income, interest for the quarter ending 2025-12-31 was $240.94K, a 54.73% decline year-over-year.
- CervoMed Inc. investment income, interest for the quarter ending 2025-09-30 was $318.79K, a 50.67% decline year-over-year.
- CervoMed Inc. investment income, interest for fiscal 2025 was $1.34M, a 31.00% decline from fiscal 2024.
- CervoMed Inc. investment income, interest for fiscal 2024 was $1.94M, a 782.94% increase from fiscal 2023.
- CervoMed Inc. investment income, interest for fiscal 2023 was $219.43K, a 252.63% increase from fiscal 2022.
- CervoMed Inc. investment income, interest for fiscal 2022 was $62.23K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $104.90K 10-Q · filed 2026-08-07 | $252.28K 10-Q · filed 2026-08-07 | $493.22K derived: sum of 3 quarters · filed 2026-08-07 | $812.01K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $147.39K 10-Q · filed 2026-05-15 | $388.32K derived: sum of 2 quarters · filed 2026-05-15 | $707.11K derived: sum of 3 quarters · filed 2026-05-15 | $1.08M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $240.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $559.73K derived: sum of 2 quarters · filed 2026-03-13 | $927.85K derived: sum of 3 quarters · filed 2026-08-07 | $1.34M 10-K · filed 2026-03-13 |
| 2025-09-30 | $318.79K 10-Q · filed 2025-11-07 | $686.91K derived: sum of 2 quarters · filed 2026-08-07 | $1.10M 10-Q · filed 2025-11-07 | $1.63M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $368.13K 10-Q · filed 2026-08-07 | $777.11K 10-Q · filed 2026-08-07 | $1.31M derived: sum of 3 quarters · filed 2026-08-07 | $1.96M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $408.99K 10-Q · filed 2026-05-15 | $941.17K derived: sum of 2 quarters · filed 2026-05-15 | $1.59M derived: sum of 3 quarters · filed 2026-05-15 | $2.27M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $532.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $1.18M derived: sum of 2 quarters · filed 2026-03-13 | $1.86M derived: sum of 3 quarters · filed 2026-03-13 | $1.94M 10-K · filed 2026-03-13 |
| 2024-09-30 | $646.17K 10-Q · filed 2025-11-07 | $1.32M derived: sum of 2 quarters · filed 2025-11-07 | $1.41M 10-Q · filed 2025-11-07 | $1.52M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $678.44K 10-Q · filed 2025-08-08 | $759.07K 10-Q · filed 2025-08-08 | $877.73K derived: sum of 3 quarters · filed 2025-08-08 | $925.39K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $80.63K 10-Q · filed 2025-05-12 | $199.28K derived: sum of 2 quarters · filed 2025-05-12 | $246.95K derived: sum of 3 quarters · filed 2025-05-12 | $264.66K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $118.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $166.32K derived: sum of 2 quarters · filed 2025-03-17 | $184.03K derived: sum of 3 quarters · filed 2025-03-17 | $219.43K 10-K · filed 2025-03-17 |
| 2023-09-30 | $47.67K 10-Q · filed 2024-11-12 | $65.37K derived: sum of 2 quarters · filed 2024-11-12 | $100.78K 10-Q · filed 2024-11-12 | $132.85K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $17.71K 10-Q · filed 2024-08-09 | $53.11K 10-Q · filed 2024-08-09 | $85.18K derived: sum of 3 quarters · filed 2024-08-09 | $106.70K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $35.40K 10-Q · filed 2024-05-14 | $67.47K derived: sum of 2 quarters · filed 2024-05-14 | $88.99K derived: sum of 3 quarters · filed 2024-05-14 | |
| 2022-12-31 | $32.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $53.59K derived: sum of 2 quarters · filed 2024-03-29 | $62.23K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $21.52K 10-Q · filed 2023-11-13 | $30.16K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |